Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs), originally designed for type 2 diabetes management have emerged as one of the most powerful pharmacological tools for sustainable weight reduction
On top of that, the injectable form carries the same practical drawbacks as other injectable peptides: needles, sterile reconstitution, refrigeration, degradation after mixing, and the ongoing friction of maintaining a regular injection routine for benefits that build gradually over months
It belongs to a class of drugs called GLP-1 receptor agonists, which help regulate blood sugar levels and appetite
Long, M., Cai, L., Li, W., Zhang, L., Guo, S., Zhang, R., Zheng, Y., Liu, X., Wang, M., Zhou, X., Wang, H., Li, X., Li, L., Zhu, Z., Yang, G., & Zheng, H
Journal of Neurology
This category is further broken down by capitalization (cap) which essentially means the size of the companies that are being invested in
US$ 29.27
US$ 20.15
US$ 28.45
US$ 25.26
